Synopsis
0
KDMF
0
NDC API
0
VMF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
51
PharmaCompass offers a list of Ammonium Glycyrrhizinate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Ammonium Glycyrrhizinate manufacturer or Ammonium Glycyrrhizinate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Ammonium Glycyrrhizinate manufacturer or Ammonium Glycyrrhizinate supplier.
A Monoammonium Glycyrrhizinate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Monoammonium Glycyrrhizinate, including repackagers and relabelers. The FDA regulates Monoammonium Glycyrrhizinate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Monoammonium Glycyrrhizinate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Monoammonium Glycyrrhizinate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.
A Monoammonium Glycyrrhizinate supplier is an individual or a company that provides Monoammonium Glycyrrhizinate active pharmaceutical ingredient (API) or Monoammonium Glycyrrhizinate finished formulations upon request. The Monoammonium Glycyrrhizinate suppliers may include Monoammonium Glycyrrhizinate API manufacturers, exporters, distributors and traders.
click here to find a list of Monoammonium Glycyrrhizinate suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
A Monoammonium Glycyrrhizinate DMF (Drug Master File) is a document detailing the whole manufacturing process of Monoammonium Glycyrrhizinate active pharmaceutical ingredient (API) in detail. Different forms of Monoammonium Glycyrrhizinate DMFs exist exist since differing nations have different regulations, such as Monoammonium Glycyrrhizinate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Monoammonium Glycyrrhizinate DMF submitted to regulatory agencies in the US is known as a USDMF. Monoammonium Glycyrrhizinate USDMF includes data on Monoammonium Glycyrrhizinate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Monoammonium Glycyrrhizinate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Monoammonium Glycyrrhizinate suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Monoammonium Glycyrrhizinate Drug Master File in Japan (Monoammonium Glycyrrhizinate JDMF) empowers Monoammonium Glycyrrhizinate API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Monoammonium Glycyrrhizinate JDMF during the approval evaluation for pharmaceutical products. At the time of Monoammonium Glycyrrhizinate JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Monoammonium Glycyrrhizinate suppliers with JDMF on PharmaCompass.
A Monoammonium Glycyrrhizinate CEP of the European Pharmacopoeia monograph is often referred to as a Monoammonium Glycyrrhizinate Certificate of Suitability (COS). The purpose of a Monoammonium Glycyrrhizinate CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Monoammonium Glycyrrhizinate EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Monoammonium Glycyrrhizinate to their clients by showing that a Monoammonium Glycyrrhizinate CEP has been issued for it. The manufacturer submits a Monoammonium Glycyrrhizinate CEP (COS) as part of the market authorization procedure, and it takes on the role of a Monoammonium Glycyrrhizinate CEP holder for the record. Additionally, the data presented in the Monoammonium Glycyrrhizinate CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Monoammonium Glycyrrhizinate DMF.
A Monoammonium Glycyrrhizinate CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Monoammonium Glycyrrhizinate CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Monoammonium Glycyrrhizinate suppliers with CEP (COS) on PharmaCompass.
A Monoammonium Glycyrrhizinate written confirmation (Monoammonium Glycyrrhizinate WC) is an official document issued by a regulatory agency to a Monoammonium Glycyrrhizinate manufacturer, verifying that the manufacturing facility of a Monoammonium Glycyrrhizinate active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Monoammonium Glycyrrhizinate APIs or Monoammonium Glycyrrhizinate finished pharmaceutical products to another nation, regulatory agencies frequently require a Monoammonium Glycyrrhizinate WC (written confirmation) as part of the regulatory process.
click here to find a list of Monoammonium Glycyrrhizinate suppliers with Written Confirmation (WC) on PharmaCompass.
Monoammonium Glycyrrhizinate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Monoammonium Glycyrrhizinate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Monoammonium Glycyrrhizinate GMP manufacturer or Monoammonium Glycyrrhizinate GMP API supplier for your needs.
A Monoammonium Glycyrrhizinate CoA (Certificate of Analysis) is a formal document that attests to Monoammonium Glycyrrhizinate's compliance with Monoammonium Glycyrrhizinate specifications and serves as a tool for batch-level quality control.
Monoammonium Glycyrrhizinate CoA mostly includes findings from lab analyses of a specific batch. For each Monoammonium Glycyrrhizinate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Monoammonium Glycyrrhizinate may be tested according to a variety of international standards, such as European Pharmacopoeia (Monoammonium Glycyrrhizinate EP), Monoammonium Glycyrrhizinate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Monoammonium Glycyrrhizinate USP).
